SCHEDULE: Logos Global Management Reduces Erasca Stake to 4.8%

Logos Global Management LP and its affiliates have reduced their beneficial ownership in Erasca, Inc. to 4.8% of the common stock.

Summary

• Logos Global Management LP, Logos Global Management GP LLC, and Arsani William (collectively, the 'Reporting Persons') jointly reported beneficial ownership of 13,600,000 shares of Erasca, Inc. Common Stock.
• This ownership represents 4.8% of Erasca, Inc.'s outstanding Common Stock.
• The percentage is calculated based on 283,670,139 shares of Common Stock outstanding on August 5, 2025, as reported in Erasca's Form 10-Q for the quarter ended June 30, 2025.
• The Reporting Persons hold shared voting and dispositive power over all 13,600,000 shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Erasca, Inc.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the reduction in a significant institutional ownership stake, which can be interpreted as a loss of confidence or a strategic divestment by a major investor.

Positives

• The continued disclosure of a significant institutional holding, even if reduced, indicates ongoing interest from Logos Global Management LP in Erasca, Inc.

Negatives

• Logos Global Management LP, along with its affiliates, has reduced its beneficial ownership in Erasca, Inc. to 4.8% of the common stock.
• This reduction signifies that the reporting persons no longer hold a stake of 5% or more, which typically triggers a Schedule 13G filing, suggesting a decrease in their investment.

Risks

• A reduction in a significant institutional investor's stake could signal a decrease in confidence in the company's future prospects or a reallocation of capital.
• Other investors might interpret this divestment as a negative indicator, potentially leading to downward pressure on the stock price.

Future Outlook

The filing does not contain any forward-looking statements or guidance from Erasca, Inc. or the reporting persons regarding the issuer's future performance.

Industry Context

Institutional investor activity, such as changes in significant ownership stakes, is closely watched in the biotechnology sector as it can reflect sentiment regarding a company's drug pipeline, clinical trial progress, or overall market positioning. A reduction in a major stake by an investment adviser like Logos Global Management could influence broader market perception of Erasca, Inc. within the industry.

Stakeholder Impact

• Shareholders: May experience negative sentiment and potential downward pressure on share price due to the reduction in institutional ownership.
• Potential Investors: May view the reduction as a cautionary signal, influencing investment decisions.

Key Dates

Recommendation

The reduction in a significant institutional stake by Logos Global Management LP to below the 5% threshold is a strong negative signal. While the filing states the holding is in the ordinary course of business, a divestment of this magnitude by a sophisticated investor often precedes or reflects underlying concerns about the company's prospects or a more attractive opportunity elsewhere. This could lead to decreased investor confidence and potential share price depreciation, warranting a 'sell' recommendation for investors currently holding the stock, or a 'avoid' for those considering entry.

Keywords

Erasca, Logos Global Management, Institutional Ownership, Beneficial Ownership, Schedule 13G, Common Stock, Biotechnology, Investment, Shareholding